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Article abstract-We investigated the association between head circumference (HC) and Alzheimer’s disease (AD) in a 
cross-sectional population-based study of aging in North Manhattan. Six hundred forty-nine subjects underwent neuro- 
logic, neuropsychological, and anthropometric evaluations; apolipoprotein E (apoE) genotype was available for a sub- 
sample of 300 individuals. Logistic regression analyses were performed with AD the outcome of interest to evaluate any 
association between HC and AD. In these analyses, HC evaluated as a continuous variable was associated with AD (OR 
0.8, 958 CI 0.7-0.9) after adjusting for age, education, and ethnicity, gender, and height. Analyses suggested that 
increased risk resided mainly in those with smallest HC. Thus, women whose HC was within the lowest quintile of HC for 
women were 2.9 (95% CI 1.4-6.1) times more likely to have AD, after adjusting for age, education, and ethnicity; and men 
in the lowest quintile of HC (for men) were 2.3 times more likely to have AD (95% CI 0.6-9.8). There was no confounding 
by height, weight, or apoE genotype. The results are consistent with previous studies that suggest that premorbid brain 
size may influence the age-specific risk for AD. Future epidemiologic studies seeking environmental risk factors for AD 
may benefit by making HC measurements on all subjects to decrease the variance associated with other potential risk 
factors. 
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The results from several studies suggest that  risk for 
Alzheimer’s disease (AD) may be associated with 
premorbid brain size. In a study of nursing home 
residents who underwent regular neuropsychological 
evaluations, Katzman et  a1.l identified a subgroup 
with larger brains who had normal cognition prior to 
death, despite autopsy evidence of underlying AD. 
The finding suggested that brain size might be a n  
important determinant of “reserve” influencing the 
timing of onset of clinical disease in patients with 
AD. In a study conducted on a convenience sample of 
28 white and African-American women, all with AD, 
we found that the age at onset of symptoms of AD 
correlated significantly with an  index of premorbid 
brain size derived from CT scans: subjects with 
larger brains had later onset of symptoms, perhaps a 
reflection of increased “reserve.’’2 In a recent study of 
1,985 Japanese-Americans over 65 years of age who 
underwent screening with the Cognitive Screening 
Abilities Instrument (CASI),3 Graves et aL4 obtained 
subjects’ head circumference (HC) measurements as 
a correlate of premorbid brain size. Analyses ad- 
justed for age, gender, and education showed that 
subjects with AD and smaller HC performed more 
poorly on the CASI than subjects with AD and larger 
HC, consistent with the hypothesis that premorbid 
brain size may influence the clinical course of the 
disease. 
In the present study, we assessed premorbid 
brain size as a possible risk factor for AD; to this end, 
we used HC as an index of premorbid brain size, a 
somewhat imprecise measure, but one adequate for our 
p ~ r p o s e s . ~  By contrast with our earlier study, which 
was based on a highly select sample of women from a 
memory disorders clinic: the current study employed 
data from a large, representative sample, including 
men and women, three different ethnic groups, and 
control subjects derived from the same population base. 
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Methods. Subjects. Data were derived from the North 
Manhattan Aging Project.'j Subjects evaluated in the sur- 
vey component of this study comprise a random sample of 
medicare recipients aged 65 years or more who reside 
within a well-defined geographic region in upper Manhat- 
tan. Ethnicity was determined by self report, or report 
from a close relative in cases of dementia, according to 
guidelines proposed by the bureau of c e n s ~ s . ~  
HC was measured to the 
nearest 0.5 cm by placing a flexible fabric tape measure 
around the head, above the eyebrows and over the occipital 
protuberance. Measurements were made by testers who 
did not participate in subjects' cognitive evaluations. 
Height was measured using a stadiometer. When subjects 
were unable to stand because of frailty or other reasons, 
the knee length was measured, and an estimated height 
calculated using the formula of Chumlea et a1.8 Weight 
was measured using a scale-tronix 5600 portable stand-on 
scale. 
ApoE status. ApoE allele type was determined by a 
previously reported m e t h ~ d . ~  
Diagnostic evaluation. All subjects in the survey Sam- 
ple were assessed at  entry into the study with a cognitive 
screening evaluation,'" based on the Comprehensive As- 
sessment and Referral Interview,ll and subsequently sub- 
jects also underwent a neuropsychological evaluation, 
which has been described in more detail e l s e ~ h e r e . ~ ~ J ~  
Briefly, the neuropsychological evaluation includes tests of 
short- and long-term m e m ~ r y , ' ~ J ~  orientation, abstract rea- 
soning,16J7 language,1s-20 and construction.21 All subjects 
who meet neuropsychological criteria for dementia, based 
on a rigidly defined paradigm of test cut scores, are also 
referred for evaluation by a clinician who determines if 
there is evidence of functional impairment due to cognitive 
decline, an additional requirement for a definitive diagno- 
sis of dementia. In addition, all subjects scoring three or 
more on the cognitive screen, and a randomly selected 25% 
of subjects who score two or less, are also referred for 
evaluation by a ~1inician.I~ All data from neuropsychologi- 
cal and clinical evaluations are reviewed at a consensus 
conference at which the definitive diagnoses are deter- 
mined. The diagnosis of probable or possible AD is made 
according to the guidelines of the NINCDS-ADRDA,22 and 
each subject is assigned a Clinical Dementia Rating 
(CDR)23 to reflect the severity of cognitive impairment 
(nondemented CDR = 0, mildly demented CDR = 1, mod- 
erately demented CDR = 2, etc.). Subjects were included in 
the current study if they had a completed diagnostic eval- 
uation, a CDR score, HC measurement, and if they were of 
Hispanic, African-American, or white ethnicity. 
We used t tests or chi-square to  
compare the mean age, years of education, height, weight, 
head circumference, and the frequency of dementia and of 
AD specifically, in the three ethnic groups, separately in 
men and women. To evaluate the association between HC 
and AD we used two analytic strategies: first, with HC as a 
categorical variable, second with HC as a continuous vari- 
able. In all analyses, all nondemented subjects in the Sam- 
ple under study were used as controls. 
For each study sample 
under analysis we created quintiles, defined by HC (ex- 
plained in greater detail later). We performed chi-square 
analyses initially, then logistic regression analyses with 
Anthropometric measures. 
Statistical analyses. 
HC as a categorical variable. 
AD the outcome, to  assess the association between HC (as 
a categorical variable) and AD. The logistic analyses were 
performed separately in men and women, and then, in 
addition, separately within ethnic-gender strata. All logis- 
tic models included age (as a continuous variable) and 
education (years of formal education) as potential con- 
founders and, whenever appropriate, gender and ethnicity, 
as specified in the results section. Additional logistic mod- 
els were also constructed to evaluate weight, height, and 
apoE status as potential confounders. 
We assessed the associa- 
tion between HC and AD in an analysis of covariance (AN- 
COVA), and then in logistic regression analyses. We used 
the ANCOVA to  compare the group mean HC of AD cases 
with the group mean HC of nondemented subjects, ad- 
justed for age, education, gender, and ethnicity. We used 
logistic analyses to obtain adjusted risk estimates for AD 
associated with HC, and to  evaluate age, education, gen- 
der, height, weight, and apoE as potential confounders of 
the association between HC and AD. 
HC as a continuous variable. 
Results. Of the 2,128 subjects who took the cognitive 
screening evaluation, a t  the time of this study 677 had 
completed a diagnostic assessment. Twenty-eight of these 
subjects were excluded from subsequent analyses because 
of unknown CDR (n = 16), HC (n = 7), or ethnicity (n = 5 ) .  
The current study is based on the remaining 649 subjects, 
of whom 375 underwent a clinician's evaluation in addition 
to the neuropsychological assessment. A total of 71% of 
subjects were female. The sample comprised 44% Hispan- 
ics, 35% African-Americans, and 21% whites; Hispanics 
had fewer years of education than whites. The mean age of 
the sample was 78.3 years (SD, 6.4) (table 1). Dementia 
was present in 84 (11%) subjects, and could not be deter- 
mined in one subject because of aphasia. Dementia was 
due to probable AD in 59 subjects and possible AD in 16. 
Demented subjects were older (84.0 versus 77.8 yr, p < 
0.001) had fewer years of schooling (5.8 versus 8.9, 
p < 0.001), and were more likely to be Hispanic (chi-square 
p < 0.01) than nondemented subjects. Because we were 
interested in the association between HC and AD, nine 
subjects with non-AD dementia were excluded from the 
subsequent analyses. We combined probable and possible 
AD cases into a single diagnostic category because both 
categories shared a similar relation to  HC in our data, as 
indicated later. 
For anthropomorphic measures, there were significant 
gender and ethnic differences with respect to height, 
weight, and head circumference (see table 1). Subjects with 
AD were significantly shorter ( p  < 0.011, lighter ( p  < 
0.001) and had smaller HC ( p  < 0.001) than nondemented 
subjects. 
Head circumference (categorical) and dementia: univar- 
iate analyses. Because of significant gender differences in 
HC, we performed univariate analyses within strata de- 
fined by gender. For each gender, we divided the popula- 
tion into approximate quintiles based on HC, and deter- 
mined the frequency of AD within each quintile (figure). 
Among women, there was a highly significant trend to- 
ward increasing frequency of AD from the quintile of 
greatest HC to  the quintile of smallest HC (Mantel- 
Haenszel [MH] test for linear association p < 0.001). In a 
similar analysis among men, there was no significant 
trend (MH test for linear association p = 0.18). Because of 
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Table 1 Subject characteristics 
~ - _- 
Females (n = 462) Males (n = 187) 
~~ _ _  
White African-Amencan Hispanic White Afncan-American Hispanic All 
(n = 88) In = 159) (n = 215) (n = 46) (n = 70) (n = 71) (n = 649) 
Age (yr) mean (SD) 79.5 (7.5) 79.3 (6.7) 77.9 (6.3) 77.0 (5.7) 77.1 (4.9) 77.3 (5.9) 78.3 (6.4) 
Ed (yr) mean (SD) 12.0 (3.4) 9.7f (3.8) 6.1*i (4.0) 12.3 (3.9) 9.4t (3.9) 6.6*t (4.0) 8.6 (4.5) 
HC (cm) mean (SD) 5 4 9  ( 1.9) 55.5 (1.9) 54.l"i 11.7) 56.8 (1.7) 57.6 (1.8) 56.2* (1.9) 55.4 (2.2) 
Height (cm) mean (SD) 154.7" (7.41 159.0 (6.4) 153.4* (6.5) 170.8 (6.1) 174.5 (10.5) 169.9* (14.1) 160.3 (11.3) 
Weight (lb) mean (SD) 145.7%' (46.4) 158.6 (37.3) 145.2* (29.3) 170.0 (25.6) 178.1 (36.8) 158.1* (21.0) 155.3 (35.7) 
Dementia no. (5%) 4 (5) 2 1  (13) 42 (20)$ 1 ( 2 )  6 (9) 10 (14) 84 (12.9) 
AD no. (96) 4 (5) 19 (12) 37 (18H l ( 2 )  5 (7) 9 (13) 75 (11.6) 
* Significantly lowerness than for African-Americans of same sex; Bonferroni correction p < 0.05. 
7 Significantly lowerfiess than for whites of same sex; Bonferroni correction p < 0.05. 
i: Chi-square p < 0.01 (conducted separately within men and women). 
Ed = education; HC = head circumference; AD = probable or possible Alzheimer's disease. 
ethnic differences in AD frequency and mean HC, we re- 
peated our analyses after further stratifying by ethnicity. 
For these analyses, approximate quintiles of HC were 
uniquely determined from the data for each gender-ethnic 
stratum. Subjects were then reclassified on the basis of 
their HC into the appropriate quintile of HC, given their 
gender and ethnicity. Of the 129 subjects in the quintile of 
lowest HC for their gender and ethnic group, 25 (19%) had 
AD, compared with 11% with AD in the second, 12% in the 
third, 11% in the fourth, and 6% in the fifth quintile of 
largest HC (chi-square p = 0.02, MH test for linear associ- 
ationp = 0.002). 
Head circumference (categorical) and AD: multivariate 
analyses. To obtain adjusted risk estimates for the asso- 
ciation between HC and AD, we undertook logistic regres- 
sion analyses with the outcome AD. We performed sepa- 
rate analyses for men and women, always adjusting for 
age and education, and adjusting for ethnicity in all anal- 
yses not restricted to a single ethnic stratum. In a prelim- 
inary logistic analysis restricted to all women, in which the 
quintile of largest HC defined the referent group, risk of 
AD was increased for the quintile of smallest HC (OR 2.5, 
95% CI 0.8-7.41, but not for the second smallest (OR 0.8), 
third (OR 0.8), or fourth quintiles (OR 0.8). These results 
suggested that increased risk for AD lay predominantly 
within the quintile of smallest HC and that it would be 
appropriate to combine subjects in the upper four quintiles 
of HC into a single referent category in subsequent analy- 
ses. In logistic regression analyses, women in the quintile 
of smallest HC were 2.9 times more likely to have AD (OR 
2.9, 95% CI 1.4-6.1) than those in the upper four quin- 
tiles. In a separate analysis among men, lowest quintile of 
HC was associated with 2.3 times the risk for prevalent 
AD compared with the upper four quintiles; however, this 
was not statistically significant (OR 2.3, 95% CI 0.6-9.8). 
We then performed similar logistic analyses separately 
within each of the six strata defined by both gender and 
ethnic group. In each logistic analysis, the referent group 
comprised subjects whose HC lay within the upper four 
quintiles of HC determined uniquely for the restricted 
sample under study-a division that was approximate, 
however, because HC had been recorded to the nearest 0.5 
I Females n=455, p for trend=0.001 
U Males n=184, p for trend=0.18 
smallest HC 2 3 4 largest HC 
Figure. Frequency of Alzheimerjs disease according to head circumference (HC) by gender. 
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Table 2 Odds ratio for Alzheimer’s disease associated with lowest quintile of head circumference* us upper four quintiles, adjusted for 
age, education 
. .  
Head circ* Number$ OR (95% CI) for OR (95% CI) for 









































































* Lowest quintile for the population strata included in the analysis. 
t Adjusted for ethnicity. 
$ Number of subjects in analyses for AD of any seventy. 
AD = probable or possible Alzheimer’s disease; CDR = Clinical Dementia Rating. 
cm. The results of these analyses are presented in table 2. 
For each analytic sample (e.g., African-American) we spec- 
ify the HC that  defined the referent group (e.g., for 
African-American women it was HC 2 54.5) and what 
proportion of the analytic sample the referent group repre- 
sented (e.g., for African-American women it was 75%). Es- 
timates of risk for AD associated with the lowest (approxi- 
mate) quintile of HC compared with the risk for subjects in 
the upper (approximate) four quintiles of HC were similar 
among African-American women (OR 2.1, 95% CI 0.7-6.61, 
white women (OR 4.5, 95% CI 0.2-100.5), and Hispanic 
women (OR 3.1, 95% CI 1.2-8.1) (see table 2). Among men, 
the analyses were limited by small numbers. Risk associ- 
ated with lowest quintile HC was not elevated in African- 
Americans, could not be calculated because of insufficient 
data in whites, but was elevated in Hispanics. Because of 
possible confounders, we repeated our  analyses including 
nondemented subjects and only AD cases with CDR of 
one-our best available index of incident cases-but there 
was little change in the risk estimates compared with 
those obtained in the entire prevalent sample (see table 2). 
Because the relationship between HC and AD might have 
been driven by inclusion of subjects with unrecognized 
mild mental retardation, with HC smaller than cognitively 
normal s ~ b j e c t s , 2 ~ , ~ ~  we performed analyses restricted to 
women who had completed at least 9 years of formal edu- 
cation; the risk associated with lowest quintile of HC re- 
mained significantly elevated (OR 5.9, 95% CI 1.5-24.5). 
As an alternative means of excluding potential cases with 
mild static encephalopathy we excluded cases of AD with 
CDR 1. Once again, the risk in women associated with 
lowest quintile HC remained significantly elevated (OR 
HC is strongly correlated with height and weight,26 
which might have been confounders in our analyses. Be- 
cause AD is also associated with weight 10ss,27,28 it would 
have been inappropriate to evaluate current weight in all 
subjects as a risk factor or confounder for the association 
between HC and AD. Fortunately, we had a history of 
recent weight loss or no recent weight loss from 544 sub- 
jects, and the usual weight by history of those who re- 
ported weight loss. We defined “common weight” as the 
measured weight in subjects with no recent weight loss, 
and the reported usual weight in subjects with recent 
weight loss. In logistic analyses adjusting for age, educa- 
tion, ethnicity, height, and common weight there was no 
association between common weight or height and preva- 
lent AD, and the risk associated with lowest quintile of HC 
remained similar to previous estimates in both men (OR 
2.7, 95% CI 0.6-12.8) and women (OR 2.4, 95% CI 1.0- 
5.6). Next, we performed logistic analyses among all 
women subjects with a history of no weight loss. In these 
analyses, lowest quintile HC remained a significant risk 
factor for prevalent AD (OR 2.9, 95% CI 1.1-7.4). In a 
separate analysis restricted to the 52 women subjects with 
a known history of weight loss, the point estimate for risk 
was higher, but did not reach statistical significance (OR 
Recent studies have demonstrated a significant associa- 
tion between I& and brain size measured by MRI within 
young adult p o p ~ l a t i o n s . ~ ~ , ~ ~ - ~ *  If premorbid I& were re- 
lated to HC in our population, it might confound the asso- 
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4.1, 95% CI 1.4-11.6). 
3.8; 95% CI, 0.8-18.5). 
Table 3 Results of logistic regression analyses predicting AD (possible or probable) 
Variable 
Subjects in whom common weight and apoE 
genotype known (n = 192) All subjects with known height (n = 628) 
- ~- - 
Univariate odds ratio Adjusted odds ratio Univariate odds ratio Adjusted odds ratio 










Head circumference (cm) 
Height (cm) 
Common weight (lb)* 
ApoE 
No €4 











































* Common weight = measured weight if no recent weight loss, otherwise = reported usual weight. 
ciation between HC and AD. To explore this possibility, we 
evaluated the relationship between performance on the 
Similarities subtest of the WAIS-R (the only WAIS-R test 
item in our neuropsychological test battery) and HC 
among nondemented subjects. In ANCOVAs adjusted for 
age, education, and ethnicity, the adjusted group mean 
performance on the Similarities subtest did not differ for 
lowest quintile HC subjects compared with those from the 
upper four quintiles of HC in either men or women, provid- 
ing limited evidence that premorbid cognitive ability could 
not be a confounder in our analyses. 
ApoE genotype was available for a subsample of 300 
subjects. ApoE status was not a confounder of HC in logis- 
tic analyses that evaluated risk for AD associated with 
lowest quintile of HC adjusted for age, education, and eth- 
nicity. 
In an  AN- 
COVA adjusted for age, gender, education. and ethnicity, 
the group mean HC of AD cases was 0.62 cm less than that 
of controls ( p  = 0.01). When the ANCOVA was restricted 
to nondemented subjects and AD subjects with CDR of 1, 
the adjusted group mean difference in HC was 0.57 cm 
( p  = 0.04). If weight loss, more common in patients with 
AD, caused loss of subcutaneous scalp fat, this might ex- 
plain a smaller mean HC in subjects with AD. To explore 
the possibility that  weight loss might decrease the HC, we 
performed analyses among nondemented subjects. In AN- 
COVAs adjusted far age, gender, education, and ethnicity, 
a history of weight loss was associated with a significant 
group mean difference in (measured) weight ( -  13.8 lb, p = 
0.004), but no significant group mean difference in HC 
(-0.27 cm, p = 0.26). This result, together with the results 
of the previous separate logistic analyses of subjects with 
and without a history of weight loss, indicates that the 
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Head circumference (continuous variable). 
association between smaller HC and AD was not an arti- 
fact of weight loss secondary to AD. 
Although our analyses suggested that AD was most as- 
sociated with lowest quintile HC and that the “categorical 
HC” approach to analysis was more appropriate, we also 
performed logistic regression analyses with HC as a con- 
tinuous variable. This permitted us to pool data from both 
sexes in a single logistic model, and to re-evaluate poten- 
tial confounders. We also used this approach to assess HC 
as a predictor, separately, of possible AD, and probable 
AD; we obtained similar point estimates of risk in both 
models, adjusted for age, education, gender, and ethnicity 
(OR for possible AD 0.8, 95% CI 0.5-1.2, OR for probable 
AD 0.8, 95% CI 0.7-1.0). The results of other analyses are 
presented in table 3. Because common weight and apoE 
status were unknown for many subjects, statistical power 
was significantly reduced for the most complete logistic 
regression model, which included both these variables. 
Therefore, we present the results of the logistic regression 
analysis conducted in the full population, which does not 
include these variables, and also the results from the most 
complete model, which derives from a much smaller Sam- 
ple. Risk estimates for univariate and adjusted logistic 
models are presented in each table. The risk associated 
with HC was similar in univariate and adjusted analyses, 
and in less complete multivariate models not presented 
here, indicating a lack of confounding by other variables 
according to the criteria of Kleinbaum et al.32 
Discussion. In a cross-sectional analysis, we have 
demonstrated an association between small HC and 
increased prevalence of AD. The result suggests that 
small premorbid brain size may be a significant risk 
factor for AD but to  sustain this view, we need to 
resolve some important questions. 
Does HC remain constant over time, or could AD 
cause a decrease in HC, explaining the association 
we observed and invalidating HC as a potential risk 
factor in cross-sectional studies? Unfortunately, we 
are aware of no longitudinal studies in which the HC 
of fully grown adults was measured repeatedly. We 
demonstrated that weight loss, more common in AD, 
seems unassociated with significant reductions in 
HC. But, could the bony cranial dimensions of sub- 
jects with AD actually decrease as a consequence of 
the cerebral atrophy that accompanies the disease? 
Longitudinal CT studies of AD subjects have not sug- 
gested that the cranial dimensions decrease with 
progression of the d i ~ e a s e . ~ ~ - ~ ~  Nevertheless, if AD 
caused a slight reduction in skull size, a small mean 
difference in HC between cases and controls might 
arise. In our study, however, AD was particularly 
associated with the lowest quintile of HC. Very sub- 
stantial reductions in skull size due to AD would be 
necessary to produce this result, if premorbid HC 
were unrelated to AD risk, and such changes should 
have been detected by longitudinal quantitative im- 
aging studies. 
Is HC a satisfactory proxy for premorbid brain 
size? Estimates of the correlation between HC and 
brain size lie between 0.2 and 0.8.5,26 Skull thickness 
may differ by gender and e t h n i ~ i t y , ~ ~ , ~ ~  so the scaling 
factor between HC and brain size probably differs by 
gender and ethnicity also. Because of this we strati- 
fied our analyses. The correlation between HC and 
brain size may be less in men than in women,29 and 
nondifferential misclassification of brain size by HC 
may therefore have been greater among men, per- 
haps accounting for the somewhat lower risk esti- 
mates associated with lowest quintile HC for men 
compared with women. Because there were fewer 
men in the analyses, our power to  detect an effect in 
men was also less. 
Did we overlook important potential confounders? 
Neither ethnicity, height, weight, educational attain- 
ment, nor apoE status were confounders in the asso- 
ciation between HC and AD. Premorbid cognitive ca- 
pacity was a potential confounder for which it was 
more difficult to  control. Subjects with AD, but high 
premorbid I&, might maintain neuropsychological 
test performance within a nondemented range longer 
into the illness, delaying the diagnosis of dementia 
in our study. High premorbid cognitive ability might 
thus function as a protective factor and, because of 
the known association with brain size, meet criteria 
as a potential confounder. In previous studies, the 
correlation between HC and measures of intelligence 
has ranged from 0.08 to 0.22.38 In our study, analy- 
ses restricted to the nondemented subjects showed 
no association between HC and performance on a 
WAIS-R subtest; this suggests that HC and cognitive 
capacity were not significantly associated in our pop- 
ulation. 
In their study of 1,985 Japanese-Americans, of 
whom 382 received clinical and neuropsychological 
evaluations, Graves et al.4 found that HC predicted 
severity of dementia in subjects with probable AD, 
with smallest HC predicting greatest impairment. 
However, HC was not associated with AD within 
their entire study sample after adjustment for age, 
gender, and educational attainment, a finding con- 
trary to  their expectations and at variance with our 
results. The authors speculated that excess mortality 
in AD subjects with smaller HC, relative to  AD sub- 
jects with larger HC, might account for this negative 
finding in their study, which included prevalent 
cases of AD. In support of this interpretation, they 
cite evidence suggesting that smaller, lighter people 
experience excess mortality compared with taller, 
heavier individuals (who might be expected to have 
greater HC).39 We cannot readily explain the discrep- 
ancy between the results of this study and ours, al- 
though ethnic and other demographic differences 
may have been important. 
Certainly, all studies, such as ours, that assess 
risk factors in relation to  prevalent cases of disease 
may be biased by differential mortality. For instance, 
small HC might appear to be a risk factor for AD if it 
were associated with a survival advantage to individ- 
uals with AD (Graves et al.4 argued that the reverse 
was actually probable). Studies of incident disease 
avoid this problem of interpretation. Although we 
did not have incident data in the current study, we 
performed one set of analyses that included cases 
with mild AD only (CDR = 1) and obtained risk 
estimates associated with HC similar to those ob- 
tained in the entire prevalent sample. We conclude 
that differential mortality by HC is unlikely to ac- 
count for our findings. 
Our results are compatible with at  least three dif- 
ferent mechanisms. First, small brain size might be 
a trait determined by genetic factors that also in- 
crease susceptibility to  AD. In this study we sought, 
but found no evidence for, an association between 
HC and the presence of the apoE €4 allele, the ge- 
netic marker most strongly associated with risk for 
AD.40 Second, small brain size might reflect expo- 
sures to environmental factors that occur during the 
period of brain maturation and growth and increase 
risk of AD independently of their effect on brain size. 
Previous investigators have identified low educa- 
tional attainment as a possible risk factor for AD.41-47 
Some have suggested that low educational attain- 
ment may be a proxy for early life exposure to  nutri- 
tional deprivation or other factors that increase risk 
for AD.48,49 The association between brain size and 
AD might be interpreted similarly. In our study, the 
association between brain size and AD was present 
after adjusting for educational attainment: if brain 
size and educational attainment are proxies for early 
life exposures, the nature of these exposures might 
be different. Finally, brain size might determine “re- 
serve,” as suggested by the findings of Katzman et 
a1.l and Schofield et a1.,2 and early life exposures 
might increase risk for clinically apparent AD as a 
July 1997 NEUROLOGY 49 35 
direct consequence of their impact on brain growth 
and development. 
In this study, there was no association between 
HC and either educational attainment or (our index 
of) premorbid cognitive capacity, two characteristics 
that might determine “reserve,” because they influ- 
ence the level of premorbid cognitive performance. 
Because HC did not appear to be a proxy for premor- 
bid cognitive ability in our sample-at least to the 
limited extent that we could assess this-our results 
suggest that brain size might mediate reserve by an 
independent mechanism based on structure. In a di- 
rect sense, brain size might determine reserve be- 
cause more neurons, more synapses, or more neural 
pathways might permit function longer into the ill- 
ness. Some other structural characteristic of larger 
brains might be protective, however, such as a 
higher ratio of glia to neurons.50-5z 
Structural brain reserve might be important at  
one or more phases of the disease. Low reserve might 
abbreviate the preclinical phase or increase the rate 
of cognitive decline once this becomes apparent, or 
both. In future studies, we plan to  investigate 
whether the rate of cognitive decline differs accord- 
ing to an index of premorbid brain size in individuals 
with cognitive impairment or AD. 
Increased risk for AD was associated with lowest 
quintile HC, perhaps reflecting low “structural brain 
reserve.” Investigators who seek new risk factors for 
AD in large epidemiologic studies might benefit by 
obtaining HC measurements in all study subjects. 
HC measurements may provide an important index 
of risk for AD, and help investigators estimate the 
risk associated with other factors with greater preci- 
sion. 
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